News Moleculin Biotech, Inc.

Equities

MBRX

US60855D3098

Delayed Nasdaq Other stock markets 10:10:35 2024-04-16 am EDT			5-day change	1st Jan Change
4.41 ^USD	-1.11%		-15.67%	-65.75%

02:12pm	Top Premarket Decliners	MT
Mar. 28	Transcript : Moleculin Biotech, Inc. - Special Call

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Top Premarket Decliners	08:12am	MT
Transcript : Moleculin Biotech, Inc. - Special Call	Mar. 28
Moleculin to Present at the MedInvest Biotech & Pharma Investor Conference	Mar. 28	PR
Moleculin to Participate in the Virtual Investor Lunch Break, the Moleculin Opportunity	Mar. 28	AQ
Sector Update: Health Care Stocks Advance Late Afternoon	Mar. 27	MT
Sector Update: Health Care	Mar. 27	MT
Moleculin Biotech Shares Rise Following Patent Announcement	Mar. 27	MT
Moleculin to Participate in the Virtual Investor Lunch Break: The Moleculin Opportunity	Mar. 27	PR
Moleculin Announces U.S. Patent Issue Notification for Annamycin Targeting Unmet Need in AML	Mar. 27	PR
Maxim Adjusts Price Target on Moleculin Biotech to $20 From $45, Maintains Buy Rating	Mar. 26	MT
Moleculin Reports Full Year 2023 Financial Results	Mar. 25	AQ
Transcript : Moleculin Biotech, Inc., 2023 Earnings Call, Mar 25, 2024	Mar. 25
Moleculin Announces Positive Interim Data in Annamycin MB-106 Phase 1B/2 AML Trial	Mar. 25	PR
Moleculin Biotech, Inc Announces Positive Interim Data in Annamycin MB-106 Phase 1B/2 AML Trial	Mar. 25	CI
Moleculin Biotech, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 22	CI
Moleculin to Report Full Year 2023 Financial Results on March 22, 2024 and Host Conference Call and Webcast	Mar. 20	PR
North American Morning Briefing : Markets on Hold as Fed Decision Nears	Mar. 20	DJ
Moleculin Biotech to Effect 1-For-15 Reverse Stock Split to Regain Compliance	Mar. 19	MT
Moleculin Announces Reverse Stock Split	Mar. 19	PR
Moleculin to Present at the 36th Annual ROTH Conference	Mar. 12	PR

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Moleculin Biotech, Inc.

Equities

MBRX

US60855D3098

Summary

Filters